Fundraising Fox
/Companies
Sign in

Xanadu Bio

Gladwyne, US · Founded 2021 · Delaware corporation

Find your way into Xanadu Bio

Biotech

Founders & leadership

TF
Taylor FeehleyChief Operating Officer
TW
Todd WiderDr. Wider is the Chief Medical Officer of the Issuer.
MS
Mark SaltzmanNamed on SEC filing
BT
Bruce TurnerNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$23M disclosed across 2 rounds · 2022–2025

▶$11MraisedAug 2025 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Taylor FeehleyExecutive Officer
  • Mark SaltzmanDirector
  • Todd WiderDirector, Executive Officer, Promoter
  • Bruce TurnerDirector, Executive Officer, Promoter
Offering amount
$11M
Amount sold
$11M
First sale
Aug 2025
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12MraisedDec 2022 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bruce TurnerExecutive Officer, Director, Promoter
  • Mark SaltzmanDirector
  • Todd WiderExecutive Officer, Director, Promoter
Offering amount
$30M
Amount sold
$12M
First sale
Aug 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Xanadu Bio raised?
Xanadu Bio has disclosed $23M raised across 2 rounds.
Where is Xanadu Bio headquartered?
Xanadu Bio is headquartered in Gladwyne, US.